Splice-modulating strategies targeting the insulin receptor: A novel therapeutic pathway in osteosarcoma

Splice-modulating strategies targeting the insulin receptor: A novel therapeutic pathway in osteosarcoma

Saved in:

Bibliographic Details
Main Authors:	Divya R. Singh, Rajvir Singh, Ramesh Balusu, Kishore B. Challagundla
Format:	Article
Language:	English
Published:	Elsevier 2025-06-01
Series:	Molecular Therapy: Oncology
Online Access:	http://www.sciencedirect.com/science/article/pii/S2950329925000591
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Employing splice-switching oligonucleotides and AAVrh74.U7 snRNA to target insulin receptor splicing and cancer hallmarks in osteosarcoma
by: Safiya Khurshid, et al.
Published: (2024-12-01)

Wnt/β-catenin signaling pathway: an attractive potential therapeutic target in osteosarcoma
by: Yi Ding, et al.
Published: (2025-02-01)

T cell receptor signaling pathway subgroups and construction of a novel prognostic model in osteosarcoma
by: Huan Xu, et al.
Published: (2025-01-01)

Dysregulation and Therapeutic Targeting of RNA Splicing Variants in Cancer
by: Doaa Rabaya, et al.
Published: (2024-09-01)

Near-infrared photoimmunotherapy for osteosarcoma targeting epidermal growth factor receptor
by: Motofumi Suzuki, et al.
Published: (2024-12-01)

Epigenetic Regulation and Therapeutic Targeting of Alternative Splicing Dysregulation in Cancer
by: Yan Lei, et al.
Published: (2025-05-01)

Targeting RNA splicing modulation: new perspectives for anticancer strategy?
by: Xuemei Lv, et al.
Published: (2025-01-01)

Impaired splicing machinery in craniopharyngiomas unveils PRPF8 and RAVER1 as novel biomarkers and therapeutic targets
by: Antonio C. Fuentes-Fayos, et al.
Published: (2025-06-01)

Osteosarcoma immune microenvironment: cellular struggle and novel therapeutic insights
by: Yi Zhang, et al.
Published: (2025-06-01)

Modulation of Neurexins Alternative Splicing by Cannabinoid Receptors 1 (CB1) Signaling
by: Elisa Innocenzi, et al.
Published: (2025-06-01)

IGLC1 is an independent prognostic marker and potent therapeutic target in osteosarcoma
by: Zhenjie Wu, et al.
Published: (2025-05-01)

The role and research progress of the MET signalling pathway in targeted therapy for osteosarcoma
by: Qilong Su, et al.
Published: (2025-06-01)

Vaccination Against Androgen Receptor Splice Variants to Immunologically Target Prostate Cancer
by: Robert D. Marek, et al.
Published: (2024-11-01)

Therapeutic targeting of the androgen receptor (AR) and AR variants in prostate cancer
by: Ramesh Narayanan
Published: (2020-07-01)

The neutrophil extracellular trap-related gene FPR1 (formyl peptide receptor 1) as a potential prognostic and therapeutic target in osteosarcoma
by: Shihao Li, et al.
Published: (2025-03-01)

Editorial: Therapeutic mechanism of osteosarcoma
by: Siyi Chen, et al.
Published: (2025-04-01)

The osteosarcoma immune microenvironment in progression: PLEK as a prognostic biomarker and therapeutic target
by: Yunpeng Zou, et al.
Published: (2025-08-01)

Splicing therapeutics for Alzheimer's disease
by: Catherine R Wasser, et al.
Published: (2016-02-01)

Clinical value of circulating splicing factors in prostate cancer: SRRM1 as a novel predictive biomarker and therapeutic target
by: Antonio J. Montero-Hidalgo, et al.
Published: (2024-12-01)

The nexus of long noncoding RNAs, splicing factors, alternative splicing and their modulations
by: Pushkar Malakar, et al.
Published: (2024-12-01)

Identification and functional characterization of T-cell exhaustion-associated lncRNA AL031775.1 in osteosarcoma: a novel therapeutic target
by: Yameng Wang, et al.
Published: (2025-02-01)

Identification of key targets and exploration of therapeutic molecular mechanisms of natural compound tangeretin in osteosarcoma
by: Ruoping Yanzhang, et al.
Published: (2025-07-01)

The Quest for Novel Cancer Biomarkers and Drug Targets in the Alternative Splicing Landscape
by: Abdullah Kahraman
Published: (2025-06-01)

NF-κB signaling pathway in osteosarcoma: from signaling networks to targeted therapy
by: Juandi Xue, et al.
Published: (2025-07-01)

Distinct Roles of apoE Receptor-2 Cytoplasmic Domain Splice Variants in Cardiometabolic Disease Modulation
by: Anja Jaeschke, et al.
Published: (2025-07-01)

Modulation of ERK and AKT pathways as the potential therapeutic targets for Toxoplasma gondii infection
by: Razieh Hosseini, et al.
Published: (2024-03-01)

Fibroblast growth factor receptor expression in hemangioblastomas: A novel therapeutic target.
by: Maya Puttonen, et al.
Published: (2025-01-01)

Targeting non-small cell lung cancer cells by dual inhibition of the insulin receptor and the insulin-like growth factor-1 receptor.
by: Emma E Vincent, et al.
Published: (2013-01-01)

Demethylzeylasteral inhibits proliferation and metastasis of osteosarcoma cells by modulating the PI3K/AKT/Autophagy pathways
by: Xuhui Yuan, et al.
Published: (2025-08-01)

Cross-species identification of PIP5K1-, splicing- and ubiquitin-related pathways as potential targets for RB1-deficient cells.
by: Andrey A Parkhitko, et al.
Published: (2021-02-01)

Identification of Nogo-B as a potential therapeutic target of osteosarcoma via stereochemically selective covalent probes
by: Jian Xue, et al.
Published: (2025-07-01)

The Potential Therapeutic Targets of Anlotinib in Osteosarcoma: Characterization Based on Patient‐Derived Xenografts and Next‐Generation Sequencing
by: Zuoyao Long, et al.
Published: (2024-12-01)

The SARS-CoV-2 UTR’s Intrudes Host RBP’s and Modulates Cellular Splicing
by: Anjali Singh, et al.
Published: (2023-01-01)

SAGE2Splice: unmapped SAGE tags reveal novel splice junctions.
by: Byron Yu-Lin Kuo, et al.
Published: (2006-04-01)

Identifying antisense oligonucleotides for targeted inhibition of insulin receptor isoform A
by: Christopher A. Galifi, et al.
Published: (2025-04-01)

Scutellarein Inhibits Osteosarcoma Growth by Targeting the TLR4/TRAF6/NF-κB Pathway
by: Shi Y, et al.
Published: (2025-01-01)

Growth hormone receptor promotes osteosarcoma cell growth and metastases
by: Mo Cheng, et al.
Published: (2020-01-01)

Potential therapeutic implications of miRNAs in osteosarcoma chemotherapy
by: Dan Chen, et al.
Published: (2017-09-01)

CGREF1 modulates osteosarcoma proliferation by regulating the cell cycle through the Wnt/β-catenin signaling pathway
by: Zicheng Wei, et al.
Published: (2024-12-01)

A novel therapeutic strategy for osteosarcoma using anti-GD2 ADC and EZH2 inhibitor
by: Jing Shan, et al.
Published: (2025-06-01)